News

The products include JHP-Rodler, Betadorm D, Rhinopront, Collomack Topical, Tirgon and Xitix. Recordati chairman and CEO Giovanni Recordati said, "The OTC pharmaceutical segment in Germany is worth around

The company begins the shipment of the product, which is the generic equivalent to Eli Lilly and Company’s Zyprexa. The product is indicated for the treatment of schizophrenia

Under the agreement, Astellas will transfer all rights and assets related to ASP3291, whose Phase IIa study is currently being initiated, to Telsar, a virtual company that will

The study has demonstrated the bioavailability enhancing properties of silica in humans, which enables active pharmaceutical ingredients to effectively absorb into the body. Grace New Business Development vice

The move follows the cGMP inspection by the Dutch authorities. TiGenix CEO Eduardo Bravo said the state-of-the-art manufacturing site is responsible for the production of innovative cell therapy

The test will measure the levels of an anti-cancer drug, 5-fluorouracil (5-FU), in the blood of cancer patients and allows oncologists to determine the optimal dose of 5-FU

The investment will increase the production of GIBCO cell culture products and secures the supply chain for Europe, Americas and Asia, the company said. Life Technologies chairman and

The company in collaboration with the University of Washington’s School of Public Health evaluated the levels of porphyrins in the urine of ASD children to determine if certain

The FDA conducted analytical tests of X-ROCK for men, which showed that products contained sildenafil and hydroxythiohomosildenafil. Hydroxythiohomosildenafil is an analogue sildenafil and is expected to possess a